One hub to rule them all

Hedge funds are not alone in this operational challenge – traditional asset managers are also affected due to the increased use of OTC derivatives in their retail funds facilitated by the loosening of investment regulations ushered in by the UCITS III directive. Several platforms are owned or sponsored by the sell side and their requirements, and as a result it is fair to say that, to date, the majority of the benefits are being realised by the sell-side institutions and not the buy side

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here